Publications by authors named "Thomas B Farb"

Claim this Profile
B
BACH2 inhibition reverses β cell failure in type 2 diabetes models.
Jinsook Son, Hongxu Ding, Thomas B Farb, Alexander M Efanov, Jiajun Sun

J Clin Invest· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonizing somatostatin receptor subtype 2 and 5 reduces blood glucose in a gut- and GLP-1R-dependent manner.
Sara L Jepsen, Nicolai J Wewer Albrechtsen, Johanne A Windeløv, Katrine D Galsgaard, Jenna E Hunt, Thomas B Farb

JCI Insight· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Episodic β-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.
Sarah A Tersey, Esther M Levasseur, Farooq Syed, Thomas B Farb, Kara S Orr

FASEB J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5.
Thomas B Farb, Marta Adeva, Thomas J Beauchamp, Over Cabrera, David A Coates

Endocrinology· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thioredoxin-mimetic peptides (TXM) inhibit inflammatory pathways associated with high-glucose and oxidative stress.
Katia Lejnev, Lena Khomsky, Krister Bokvist, Shani Mistriel-Zerbib, Tahel Naveh, Thomas Bradley Farb

Free Radic Biol Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectonucleotidase NTPDase3 is abundant in pancreatic β-cells and regulates glucose-induced insulin secretion.
Samreen K Syed, Audra L Kauffman, Lisa S Beavers, James T Alston, Thomas B Farb

Am J Physiol Endocrinol Metab· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a novel polyclonal anti-hypusine antibody.
Yurika Nishiki, Thomas B Farb, Jessica Friedrich, Krister Bokvist, Raghavendra G Mirmira

Springerplus· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule allosteric modulation of the glucagon-like Peptide-1 receptor enhances the insulinotropic effect of oxyntomodulin.
Francis S Willard, Denise Wootten, Aaron D Showalter, Emilia E Savage, James Ficorilli, Thomas B Farb

Mol Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of GPR119 receptor activity with endocannabinoid-like lipids.
Samreen K Syed, Hai Hoang Bui, Lisa S Beavers, Thomas B Farb, James Ficorilli

Am J Physiol Endocrinol Metab· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.
Kyle W Sloop, Francis S Willard, Martin B Brenner, James Ficorilli, Kathleen Valasek, Thomas B Farb

Diabetes· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of deoxyhypusine synthase enhances islet {beta} cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes.
Reiesha D Robbins, Sarah A Tersey, Takeshi Ogihara, Dhananjay Gupta, Thomas B Farb

J Biol Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis